Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to RBD1016 for the ...

Estimates show the variant accounts for over 51% of all new cases nationwide. A highly contagious variant of the novel coronavirus that was initially identified in India is now the dominant strain in ...

SAN FRANCISCO (KGO) -- The Centers for Disease Control and Prevention (CDC) released new data Friday indicating the Delta variant is twice as infectious as previously thought, and a recent analysis ...

SAN FRANCISCO -- Earlier in the pandemic, experts had hoped if we can get 75% of Americans vaccinated, we can contain the coronavirus. Thursday, we're at just over 50% vaccinated. But 75% is no longer ...

Assembly Biosciences Inc (($ASMB)) announced an update on their ongoing clinical study. Assembly Biosciences Inc. is conducting a Phase 1a ...

GRAND JUNCTION, Colo. (KJCT) - Officials have confirmed that two people have tested positive for West Nile Virus in Delta County. Delta County Public Health (DCPH) says one person is an 80+ year old ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...

First patient enrolled in ECLIPSE 1 Phase 3 clinical trial evaluating combination of tobevibart and elebsiran for chronic suppressive treatment ECLIPSE program designed to enable regulatory ...

EMA grants Orphan Drug Designation to Ribo’s siRNA therapeutic RBD1016 for Hepatitis Delta Virus infection: Beijing, China Saturday, October 25, 2025, 17:00 Hrs [IST] Suzhou Rib ...

Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that the European Medicines Agency ...